Literature DB >> 19914457

Epidemiology, staging (new system), and prognosis of cutaneous melanoma.

Younghoon R Cho1, Melissa P Chiang.   

Abstract

Melanoma remains one of the most deadly of skin cancers and its incidence has been rising steadily throughout the past several decades. The risk factors associated with melanoma include external factors, such as exposure to ultraviolet radiation, and host factors, such as family history, history of dysplastic nevi, and number of nevi. The 2002 American Joint Committee on Cancer tumor-nodes-metastasis staging classification incorporates Breslow depth, Clark's level, ulceration, pathologic microstaging attributes, and nodal and distant metastases. Prognosis remains poor for advanced disease and surgery remains the mainstay of treatment for early stage melanoma.

Entities:  

Mesh:

Year:  2010        PMID: 19914457     DOI: 10.1016/j.cps.2009.07.001

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  7 in total

1.  Image and statistical analysis of melanocytic histology.

Authors:  Jayson Miedema; James Stephen Marron; Marc Niethammer; David Borland; John Woosley; Jason Coposky; Susan Wei; Howard Reisner; Nancy E Thomas
Journal:  Histopathology       Date:  2012-06-11       Impact factor: 5.087

2.  A mouse model of melanoma driven by oncogenic KRAS.

Authors:  Carla Milagre; Nathalie Dhomen; Felipe C Geyer; Robert Hayward; Maryou Lambros; Jorge S Reis-Filho; Richard Marais
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

3.  Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.

Authors:  Hao Feng; Xiao-Min Jia; Ni-Na Gao; Hua Tang; Wei Huang; Ning Ning
Journal:  Cell Cycle       Date:  2019-09-04       Impact factor: 4.534

4.  Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase.

Authors:  Luana Lugini; Ilaria Sciamanna; Cristina Federici; Elisabetta Iessi; Enrico Pierluigi Spugnini; Stefano Fais
Journal:  Oncotarget       Date:  2017-01-17

5.  A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment.

Authors:  Rongzhi Huang; Min Mao; Yunxin Lu; Qingliang Yu; Liang Liao
Journal:  Aging (Albany NY)       Date:  2020-04-20       Impact factor: 5.682

6.  The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma.

Authors:  Huijie Jia; Wenjing Ren; Yuchen Feng; Tian Wei; Mengmeng Guo; Jing Guo; Jingjing Zhao; Xiangfeng Song; Mingyong Wang; Tiesuo Zhao; Hui Wang; Zhiwei Feng; Zhongwei Tian
Journal:  Int J Oncol       Date:  2018-07-06       Impact factor: 5.650

Review 7.  Risk factors for positive sentinel lymph nodes in head and neck melanoma - a survival analysis.

Authors:  Neide Lira Bonachela; Luiz Paulo Kowalski; André Bandiera de Oliveira Santos
Journal:  Braz J Otorhinolaryngol       Date:  2020-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.